Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bernhard

Showing results (131-140 of 250) with videos related to

Pageof 25
Sort By:
Journal of Gambling Studies|June 9, 2022
Open Science Practices in Gambling Research Publications (2016-2019): A Scoping ReviewEric R Louderback, Sally M Gainsbury, Robert M Heirene, et al.
Experimental Cell Research|August 26, 1998
Caffeine and staurosporine enhance the cytotoxicity of cisplatin and camptothecin in human brain tumor cell linesA J Janss, C Levow, E J Bernhard, et al.
Translational Oncology|March 8, 2016
Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and RecommendationsHelen B Stone, Eric J Bernhard, C Norman Coleman, et al.
Cancer|May 1, 1997
A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, SwitzerlandH P Schmid, R Maibach, J Bernhard, et al.
Journal of Agricultural and Food Chemistry|April 13, 2010
Hydrolysis and speciation of Al bound to pectin and plant cell wall material and its reaction with the dye chrome azurol SJ Bernhard Wehr, F P C Blamey, J V Hanna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer--a lesson from the real world--the Swiss Group for Clinical Cancer Research SAKKC Hürny, J Bernhard, R Joss, et al.
Cancer Research|March 31, 2001
The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-rasE Cohen-Jonathan, S M Evans, C J Koch, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]V Comat, G Pierquet, G Pierquet, et al.
Cancer Research|April 15, 1996
The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblastsE J Bernhard, G Kao, A D Cox, et al.
Cancer Research|September 17, 2005
Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-RasThomas B Brunner, Keith A Cengel, Stephen M Hahn, et al.
Pageof 25

Showing results (131-140 of 250) with videos related to

Sort By:
Pageof 25
Journal of Gambling Studies|June 9, 2022
Open Science Practices in Gambling Research Publications (2016-2019): A Scoping ReviewEric R Louderback, Sally M Gainsbury, Robert M Heirene, et al.
Experimental Cell Research|August 26, 1998
Caffeine and staurosporine enhance the cytotoxicity of cisplatin and camptothecin in human brain tumor cell linesA J Janss, C Levow, E J Bernhard, et al.
Translational Oncology|March 8, 2016
Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and RecommendationsHelen B Stone, Eric J Bernhard, C Norman Coleman, et al.
Cancer|May 1, 1997
A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, SwitzerlandH P Schmid, R Maibach, J Bernhard, et al.
Journal of Agricultural and Food Chemistry|April 13, 2010
Hydrolysis and speciation of Al bound to pectin and plant cell wall material and its reaction with the dye chrome azurol SJ Bernhard Wehr, F P C Blamey, J V Hanna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer--a lesson from the real world--the Swiss Group for Clinical Cancer Research SAKKC Hürny, J Bernhard, R Joss, et al.
Cancer Research|March 31, 2001
The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-rasE Cohen-Jonathan, S M Evans, C J Koch, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|November 7, 2015
[Not Available]V Comat, G Pierquet, G Pierquet, et al.
Cancer Research|April 15, 1996
The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblastsE J Bernhard, G Kao, A D Cox, et al.
Cancer Research|September 17, 2005
Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-RasThomas B Brunner, Keith A Cengel, Stephen M Hahn, et al.
Pageof 25